
APDN Appoints Clay Shorrock as Chief Legal Officer and Executive Director of Business Development
April 1st, 2021
APDN Appoints Clay Shorrock as Chief Legal Officer and Executive Director of Business Development
April 1st, 2021
APDN Receives Purchase Order for 10,000 Linea™ COVID-19 Assay Kits
March 11th, 2021
Linea™ COVID-19 Selective Genomic Surveillance™ Mutation Panel
March 9th, 2021
Applied DNA to Participate in Upcoming Conferences
March 8th, 2021
Clinical Trial to Evaluate LinearDNA COVID-19 Vaccine Candidate for Felines
March 2nd, 2021
APDN Granted US Patent Covering Methods of Utilizing DNA Tagged Submicron Particles for Authentication
February 25th, 2021
APDN to Provide COVID-19 Surveillance Testing to LIM College
February 19th, 2021
FY’21 Q1 Revenues at Upper End of Guided Range
February 11th, 2021
Applied DNA and Cytocheck Detect First Instance of SARS-CoV-2 B.1.1.7 Variant in Kansas
February 11th, 2021